McGuire noted that earlier studies showed no evidence of macrovascular benefit of glycemic treatment of type 2 diabetes, and that although there was nearly significant reduction in myocardial infarction in the UKPDS, there was a comparable degree of increase in stroke.
← all excerpts
2009 World Congress on the Insulin Resistance Syndrome: cardiovascular disease concepts.
1
—
—